Pharma may see recovery with FY19 profit set to jump 20-22%: Crisil

This will be primarily on the back of strong growth in the overseas market, particularly in the regulated markets of the US and the EU, it said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news